Business

The companies first partnered in 2020 to develop a prescription digital therapeutic for schizophrenia. They said a treatment strategy for the condition "would benefit from a multi-product approach."

Click Therapeutics received FDA Breakthrough Device Designation for a prescription digital therapeutic for episodic migraine, and Superior HealthPlan announced a home care partnership with MedArrive and Brave Health.

Also, a Thai language speech recognition AI has been deployed for screening depression in Thailand.

It delivers ethnicity-specific brain scan analysis within 20 minutes.

Disease detection company Cardiosense, sustainable pill bottle maker Cabinet Health, testing company LumiraDx and physician engagement platform KeyOps also garner investments.

The deal is expected to close in January 2023.

According to TechCrunch and Fierce Healthcare, the health data company also recently closed a $200 million structured equity infusion.

The companies also raised $13 million in funding to support the merger.

The tool embeds in the EHR and allows providers to write care workflows that deliver best practices and next steps.

The company will use the investment to expand its technology's current abilities, add capabilities to detect additional health conditions and drive global growth.